Baidu
map

JACC:诊断心肌梗死(MI)新标志物--心肌肌钙蛋白

2015-06-02 徐媛媛译 MedSci原创

诊断心肌梗塞(MI)心肌肌钙蛋白是首选生物标志物。本研究目的将高敏心肌肌钙蛋白T(hs-cTnT)引入到临床并定义高敏心肌肌钙蛋白T在什么情况下会升高。使用Elecsys肌钙蛋白T高敏检验方法。 最新SWEDEHEART注册分析数据显示,新型高敏心肌肌钙蛋白试验能够识别大部分患者(多无心梗)的心肌肌钙蛋白微量升高。 研究人员对48594名因疑似急性冠脉综合征入院的患者进行了分析。根据患者高敏心

诊断心肌梗塞(MI)心肌肌钙蛋白是首选生物标志物。本研究目的将高敏心肌肌钙蛋白T(hs-cTnT)引入到临床并定义高敏心肌肌钙蛋白T在什么情况下会升高。使用Elecsys肌钙蛋白T高敏检验方法。

最新SWEDEHEART注册分析数据显示,新型高敏心肌肌钙蛋白试验能够识别大部分患者(多无心梗)的心肌肌钙蛋白微量升高。

研究人员对48594名因疑似急性冠脉综合征入院的患者进行了分析。根据患者高敏心肌肌钙蛋白T水平进行分类,第一组<6 ng/L ;第二组6 ng/L~13 ng/L;第三组14 ng/L~49 ng/L(一组中,大多数患者都会有心肌肌钙蛋白T与年长的化验);第四组≥50 ng/L。

第1,2,3,4组分别有5790名 (11.9%), 6491名 (13.4%), 10476 名(21.6%)和25837名 (53.2%)患者。使用Elecsys肌钙蛋白T高敏检验方得在第1-4组中,心梗患者占不同高敏心肌肌钙蛋白水平群体的百分比,分别为2.2%, 2.6%, 18.2%和81.2%。在随访期间,患者显著冠脉狭窄、左心室收缩功能不全与死亡的比例逐步增加。根据高敏心肌肌钙蛋白水平将患者分为20组时,高敏心肌肌钙蛋白T水平在14 ng/L时的校正死亡率升高。心肌肌钙蛋白含量升高的患者发生缺血事件的风险会升高。

原始出处

Melki D1, Lugneg?rd J2, Alfredsson J3, Lind S4, Eggers KM2, Lindahl B2, Jernberg T5.Implications of Introducing High-Sensitivity Cardiac Troponin T Into Clinical Practice: Data From the SWEDEHEART Registry.J Am Coll Cardiol. 2015 Apr 28

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1840841, encodeId=bbe3184084137, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Oct 11 16:04:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853351, encodeId=be2918533516b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Apr 09 08:04:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325041, encodeId=a33a13250417a, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490302, encodeId=808414903021c, content=<a href='/topic/show?id=72a651322e0' target=_blank style='color:#2F92EE;'>#心肌肌钙蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51322, encryptionId=72a651322e0, topicName=心肌肌钙蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1de58724110, createdName=wrj0124, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25764, encodeId=ba2a25e64b8, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jasonuclear, createdTime=Tue Jun 02 13:41:00 CST 2015, time=2015-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25759, encodeId=f9bd25e59e9, content=研究很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Tue Jun 02 13:14:00 CST 2015, time=2015-06-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1840841, encodeId=bbe3184084137, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Oct 11 16:04:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853351, encodeId=be2918533516b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Apr 09 08:04:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325041, encodeId=a33a13250417a, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490302, encodeId=808414903021c, content=<a href='/topic/show?id=72a651322e0' target=_blank style='color:#2F92EE;'>#心肌肌钙蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51322, encryptionId=72a651322e0, topicName=心肌肌钙蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1de58724110, createdName=wrj0124, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25764, encodeId=ba2a25e64b8, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jasonuclear, createdTime=Tue Jun 02 13:41:00 CST 2015, time=2015-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25759, encodeId=f9bd25e59e9, content=研究很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Tue Jun 02 13:14:00 CST 2015, time=2015-06-02, status=1, ipAttribution=)]
    2016-04-09 hbwxf
  3. [GetPortalCommentsPageByObjectIdResponse(id=1840841, encodeId=bbe3184084137, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Oct 11 16:04:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853351, encodeId=be2918533516b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Apr 09 08:04:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325041, encodeId=a33a13250417a, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490302, encodeId=808414903021c, content=<a href='/topic/show?id=72a651322e0' target=_blank style='color:#2F92EE;'>#心肌肌钙蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51322, encryptionId=72a651322e0, topicName=心肌肌钙蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1de58724110, createdName=wrj0124, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25764, encodeId=ba2a25e64b8, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jasonuclear, createdTime=Tue Jun 02 13:41:00 CST 2015, time=2015-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25759, encodeId=f9bd25e59e9, content=研究很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Tue Jun 02 13:14:00 CST 2015, time=2015-06-02, status=1, ipAttribution=)]
    2015-06-04 heli0118
  4. [GetPortalCommentsPageByObjectIdResponse(id=1840841, encodeId=bbe3184084137, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Oct 11 16:04:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853351, encodeId=be2918533516b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Apr 09 08:04:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325041, encodeId=a33a13250417a, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490302, encodeId=808414903021c, content=<a href='/topic/show?id=72a651322e0' target=_blank style='color:#2F92EE;'>#心肌肌钙蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51322, encryptionId=72a651322e0, topicName=心肌肌钙蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1de58724110, createdName=wrj0124, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25764, encodeId=ba2a25e64b8, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jasonuclear, createdTime=Tue Jun 02 13:41:00 CST 2015, time=2015-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25759, encodeId=f9bd25e59e9, content=研究很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Tue Jun 02 13:14:00 CST 2015, time=2015-06-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1840841, encodeId=bbe3184084137, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Oct 11 16:04:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853351, encodeId=be2918533516b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Apr 09 08:04:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325041, encodeId=a33a13250417a, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490302, encodeId=808414903021c, content=<a href='/topic/show?id=72a651322e0' target=_blank style='color:#2F92EE;'>#心肌肌钙蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51322, encryptionId=72a651322e0, topicName=心肌肌钙蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1de58724110, createdName=wrj0124, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25764, encodeId=ba2a25e64b8, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jasonuclear, createdTime=Tue Jun 02 13:41:00 CST 2015, time=2015-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25759, encodeId=f9bd25e59e9, content=研究很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Tue Jun 02 13:14:00 CST 2015, time=2015-06-02, status=1, ipAttribution=)]
    2015-06-02 jasonuclear

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1840841, encodeId=bbe3184084137, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Oct 11 16:04:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853351, encodeId=be2918533516b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Apr 09 08:04:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325041, encodeId=a33a13250417a, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490302, encodeId=808414903021c, content=<a href='/topic/show?id=72a651322e0' target=_blank style='color:#2F92EE;'>#心肌肌钙蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51322, encryptionId=72a651322e0, topicName=心肌肌钙蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1de58724110, createdName=wrj0124, createdTime=Thu Jun 04 02:04:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25764, encodeId=ba2a25e64b8, content=嗯, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jasonuclear, createdTime=Tue Jun 02 13:41:00 CST 2015, time=2015-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25759, encodeId=f9bd25e59e9, content=研究很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Tue Jun 02 13:14:00 CST 2015, time=2015-06-02, status=1, ipAttribution=)]
    2015-06-02 hbwang006

    研究很多

    0

相关资讯

JACC:PCI术后自发性出血和心肌梗死增加患者的远期死亡率

美国加州大学旧金山分校Dhruv S. Kazi博士等人,研究了PCI术后患者出血和心肌梗死与远期死亡率之间的关联性,其研究成果发表在4月份Journal of the American College of Cardiology期刊上。 背景: 经皮冠状动脉介入治疗(PCI)后使用血小板抑制剂能够降低心肌梗死(MI)的风险,但同时也会增加患者出血风险。PCI术后住院期间MI和出血与远

Circulation:房颤与非ST段抬高心肌梗死(NSTEMI)相关

    最近有报道说,房颤[AF]与心肌梗死[MI]的风险增加有关。然而,这种关联背后的机理目前尚不清楚。未来对心肌梗死[ST段抬高心肌梗死(STEMI)与非ST段抬高心肌梗死(NSTEMI)]的AF患者类型的关系的进一步研究可能揭示潜在机制。    我们从14462参与者[平均年龄54岁,56%为女性,26%的非裔美国人]中研究AF和MI事件的联系,患者来

Nat Commun:华人研究,自噬调节心肌梗死新模式

近日,来自青岛大学的研究人员在国际学术期刊nature communication在线发表了他们的最新研究进展,他们发现一种叫做自噬促进因子(APF)的长非编码RNA能够通过靶向miR-188-3p和ATG7调节自噬,在心肌梗死诊断和治疗方面具有一定意义。   细胞自噬是对环境应激的一种进化保守应答过程。在自噬发生过程中,细胞内冗余成分如异常聚集的蛋白质和损伤的细胞器会被自噬小泡

Circulation:房颤增加心肌梗死的风险,在女性中尤为突出

国温斯顿沙兰维克森林大学Elsayed Z. Soliman博士等人研究了房颤患者与心衰之间的关联,并且比较了STEMI与NSTEMI之间的差异性,其研究成果发表在4月份Circulation期刊上。 背景: 研究显示,房颤[AF]能够增加心肌梗死[MI]的风险。然而,两者之间的关联,其背后的机理目前尚不清楚。对房颤与心肌梗死(ST段抬高型心肌梗死(STEMI)与非ST段抬高型心肌梗死[NSTEM

JACC:心肌梗死术后住院多久更好?

住院时间长短是医疗护理效率的一个重要的量度,这必须小心谨慎地与医疗治疗相平衡。缩短住院时间主要是降低经济方面的压力。但是,更长的住院时间考虑到了提高以病人为中心的治疗并过渡到门诊部,这可以降低再住院率并提高医疗结果。对于经皮冠状动脉介入治疗的ST段抬高的心肌梗死病人来说,住院时间的长短对疾病的治疗有着很重要的影响。这一类病人需要住院监测心律失常和心肌梗死的并发症。 科研人员调查了国家心血管数

Circulation:不同厂家hs-cTnI确诊心肌梗死存在较高不一致性

由于当前监管过程中的局限性,急性心肌梗死(AMI)的误诊可能显著损害患者利益,并可能导致不恰当的心肌肌钙蛋白(cTn)的临床决策值(CDV)。在国际多中心的前瞻性研究中,巴塞尔大学医院心内科的研究人员们在2300例疑似急性心肌梗死患者中使用临床表征和临床使用的高灵敏度cTn检验(雅培hs-cTnI与罗氏的hs-cTnT)来确定AMI诊断不一致的数量。研究人员假设,两个实验的核定CDV不是生物学等价

Baidu
map
Baidu
map
Baidu
map